The high percentage of CD14+CD16+ monocytes in severe COVID-19 patients have been demonstrated in two studies [71,72], which are specialized in producing inflammatory mediators including GM-CSF and IL-6, IL-10, and TNF-α. The gene discussed is IL6; the disease is COVID-19.